BUZZ-J.P.Morgan upgrades Bath & Body Works to 'overweight'

J.P.Morgan upgrades beauty and skincare firm Bath & Body Works BBWI.N to "overweight" from "neutral", citing potential for revenue growth in FY25

Brokerage sees BBWI's "three-legged stool" of product innovation, marketing and technology supporting growth within its "core" categories of home fragrance, body care, and hand soaps/sanitizers

J.P.Morgan raises target price to $47 from $41, representing a ~29% upside from last close

Brokerage says, "We see sales growth and therefore fixed cost leverage as the primary driver to bridge operating margins to management's ~20% long-term target"

13 of 19 brokerages rate the stock "buy" or higher, 5 "hold" and 1 "sell" or lower; their median PT is $45

Up to last close, BBWI stock which fell 10% in 2024, was down 6% YTD in 2025